These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6887535)

  • 1. [Immunotherapy of malignant lymphoma].
    Konaka Y; Takiguchi T; Konda S
    Rinsho Ketsueki; 1983 Apr; 24(4):337-46. PubMed ID: 6887535
    [No Abstract]   [Full Text] [Related]  

  • 2. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y; Inamoto T; Hori T; Kan N; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):597-608. PubMed ID: 4056544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of T-cell lymphoma with immunotherapy of OK-432--a case report (author's transl)].
    Nakayama S; Tsuji K; Kitajima K; Ueno K; Hoshino T
    Rinsho Ketsueki; 1980 Jan; 21(1):66-72. PubMed ID: 6966340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432].
    Ogawa Y; Maeda T; Yoshida S; Yamamoto Y; Morita M; Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):946-50. PubMed ID: 6413627
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
    Nio Y; Inamoto T; Kan N; Hori T; Nakayama N; Yamasaki N; Hikasa Y; Tsuchitani T; Ban S; Nagai T
    Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):803-10. PubMed ID: 6491430
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
    Misawa S; Sawai K; Takino T; Masuda M; Abe T; Kawai K
    Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):291-305. PubMed ID: 479655
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy with allogeneic immune peritoneal cells.
    Dullens HF; Den Otter W
    Cancer Res; 1974 Jul; 34(7):1726-30. PubMed ID: 4833917
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in peripheral lymphocyte subsets before and after OK-432 administration in liver cancer].
    Yamamoto S; Omoto K; Yamamoto R; Ideguchi S; Oumi T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1077-8. PubMed ID: 3963851
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Local immunotherapy of malignant brain tumors. Evaluation of intratumoral injection of BCG and a Streptococcus pyogenes preparation].
    Tanaka R; Sekiguchi K; Suzuki Y; Sobue H; Takeda N; Murakami N
    Neurol Med Chir (Tokyo); 1984 Jun; 24(6):376-84. PubMed ID: 6206423
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intracerebral picibanil injection in the rat neurogenic tumor--its histopathological changes].
    Tokuriki Y; Takeuchi J; Handa H; Oda Y
    No Shinkei Geka; 1982 Jun; 10(6):607-16. PubMed ID: 7121728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of indomethacin in non-specific immunotherapy].
    Ohshika Y; Umesaki N; Kawabata M; Sako H; Sugawa T
    Nihon Gan Chiryo Gakkai Shi; 1986 Aug; 21(7):1433-9. PubMed ID: 3491171
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
    [No Abstract]   [Full Text] [Related]  

  • 14. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
    Kodama M; Tanaka T
    Hiroshima J Med Sci; 1983 Jun; 32(2):167-71. PubMed ID: 6618899
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and experimental studies on immunotherapy in malignant lymphoma.
    Kimura I
    Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1142-51. PubMed ID: 155971
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems in immunotherapy of gynecologic malignancy].
    Kanazawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Sep; 33(9):1336-44. PubMed ID: 7196936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytologic changes following intratumoral high dose injection of OK-432 in advanced pancreatic cancers and gall bladder cancers with ultrasound guidance].
    Okano Y; Takenaka A; Kasugai H; Morii T; Kishigami Y; Okuda S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1892-3. PubMed ID: 6882009
    [No Abstract]   [Full Text] [Related]  

  • 18. Parameters of serum complement in relation to tumor therapy.
    Drake WP; Mardiney MR
    Biomedicine; 1974 May; 21(5):206-9. PubMed ID: 4433667
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a streptococcal preparation, OK-432, on hematopoietic spleen colony formation in irradiated mice.
    Hiraoka A; Yamagishi M; Ohkubo T; Kamamoto T; Yoshida Y; Uchino H
    Cancer Res; 1981 Jul; 41(7):2954-8. PubMed ID: 7018674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients.
    Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H
    Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.